We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMRD
5851
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$19K ﹤0.01%
+2,078
New +$14.8K
AVCT
5852
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$19K ﹤0.01%
+390
New +$13.8K
AMU
5853
DELISTED
ETRACS Alerian MLP Index ETN
AMU
$19K ﹤0.01%
2,273
-1,893
-45% -$15.7K
ALOT icon
5854
AstroNova
ALOT
$225M
$18K ﹤0.01%
2,301
+14
+0.6% +$92
FBRX icon
5855
Forte Biosciences
FBRX
$1.57B
$18K ﹤0.01%
49
-796
-94% -$356K
IBUY icon
5856
Amplify Online Retail ETF
IBUY
$111M
$18K ﹤0.01%
247
+211
+586% +$12.4K
LYRA
5857
DELISTED
LYRA THERAPEUTICS INC
LYRA
$18K ﹤0.01%
+32
New +$23.4K
MTLS
5858
Materialise
MTLS
$368M
$18K ﹤0.01%
799
-52
-6% -$1.14K
TRX icon
5859
TRX Gold Corp
TRX
$254M
$18K ﹤0.01%
20,890
XWEL icon
5860
XWELL
XWEL
$8.28M
$18K ﹤0.01%
209
+206
+6,867% +$10.8K
PMD
5861
DELISTED
Psychemedics Corporation
PMD
$18K ﹤0.01%
3,178
-4,398
-58% -$24.6K
ASLN
5862
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$18K ﹤0.01%
235
-87
-27% -$5.91K
NGE
5863
DELISTED
Global X MSCI Nigeria ETF
NGE
$18K ﹤0.01%
1,889
-49
-3% -$454
HPR
5864
DELISTED
HighPoint Resources Corporation
HPR
$18K ﹤0.01%
1,156
-4,559
-80% -$66.1K
ALBT
5865
DELISTED
Avalon GloboCare
ALBT
$17K ﹤0.01%
58
+33
+132% +$8.06K
AYTU icon
5866
AYTU BioPharma
AYTU
$23.9M
$17K ﹤0.01%
60
+51
+567% +$15.4K
ELA icon
5867
Envela
ELA
$563M
$17K ﹤0.01%
+2,738
New +$10K
NINE
5868
DELISTED
Nine Energy Service
NINE
$17K ﹤0.01%
9,006
+5,442
+153% +$9.15K
SNGX icon
5869
Soligenix
SNGX
$5.54M
$17K ﹤0.01%
35
-21
-38% -$8.65K
VOC icon
5870
VOC Energy
VOC
$50.7M
$17K ﹤0.01%
6,881
+33
+0.5% +$67
ATYR
5871
aTyr Pharma
ATYR
$47.6M
$17K ﹤0.01%
+3,744
New +$13.6K
AIVC
5872
Amplify Bloomberg AI Equal Weight ETF
AIVC
$113M
$17K ﹤0.01%
425
-3,050
-88% -$103K
AAAU icon
5873
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.46B
$16K ﹤0.01%
+895
New +$15.3K
BGFV
5874
DELISTED
Big 5 Sporting Goods
BGFV
$16K ﹤0.01%
8,350
+898
+12% +$1.35K
EIC
5875
Eagle Point Income Co
EIC
$230M
$16K ﹤0.01%
1,250

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.